SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-09-000088
Filing Date
2009-01-27
Accepted
2009-01-27 16:24:04
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 309096
  Complete submission text file 0000898432-09-000088.txt   311335
Mailing Address 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 6109415231
GENAERA CORP (Subject) CIK: 0000880431 (see all company filings)

IRS No.: 133445668 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42170 | Film No.: 09548416
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice